Metabolism - Clinical and Experimental
Volume 44 , Pages 24-32 , October 1995

Intracellular signaling by growth factors

  • Klaus Seedorf

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Klaus Seedorf, PhD, Hagedorn Research Institute, Department of Molecular Signaling, Niels Steensens Vej 6, 2820 Gentofte, Denmark.

References 

  1. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 1990;61:203–212
  2. Schlessinger J, Ullrich A. Growth factor signaling by receptors tyrosine kinases. Neuron. 1992;9:383–391
  3. Fantl WJ, Johnson DE, Williams LT. Signalling by receptor tyrosine kinases. Annu Rev Biochem. 1993;62:453–481
  4. Koch CA, Anderson D, Moran MF, et al.  SH2 and SH3 domains: Elements that control interactions of cytoplasmic signaling proteins. Science. 1991;252:668–674
  5. Waksman G, Shoelson SE, Pant N, et al.  Binding of high affinity phosphotyrosyl peptide to the srcSH2 domain: Crystal structures of the complexed and peptide free form. Cell. 1993;72:779–790
  6. Pawson T, Schlessinger J. SH2 and SH3 domains. Curr Biol. 1993;3:434–442
  7. Anderson D, Kock CA, Grey L, et al.  Binding of SH2 domains of PLC gamma 1, GAP, and src to activated growth factor receptors. Science. 1990;250:979–982
  8. Margolis B, Li N, Koch A, et al.  The tyrosine phosphorylated carboxy terminus of the EGF receptor is a binding site for GAP and PLCγ. EMBO J. 1990;9:4375–4380
  9. Vogel W, Lammers R, Huang J, et al.  Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. Science. 1993;259:1611–1614
  10. Hu P, Margolis B, Skolnik EY, et al.  Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Mol Cell Biol. 1992;12:981–990
  11. McGlade CJ, Ellis C, Reedijk M, et al.  SH2 domains of the p85α subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors. Mol Cell Biol. 1992;12:991–997
  12. Pelicci G, Lanfrancone L, Grignani F, et al.  A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell. 1993;70:93–104
  13. Lowenstein EJ, Daly RJ, Batzer AG, et al.  The SH2 and SH3-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell. 1992;70:431–442
  14. Li W, Hu P, Skolnik EY, et al.  SH2 and SH3 containing Nck protein is oncogenic and a common target for different surface receptors. Mol Cell Biol. 1992;12:5824–5833
  15. Soler C, Beguinot L, Carpenter G. Individual EGF-R autophosphorylation sites do not stringently define association motifs for several SH2-containing proteins. J Biol Chem. 1994;269:12320–12324
  16. Rozakis-Adcock M, McGlade J, Mbamalu G, et al.  Association of Shc and SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature. 1992;360:689–692
  17. Obermeier A, Halfter H, Wiesmüller K-H, et al.  Tyrosine 785 is a major determinant of Trk-substrate interaction. EMBO J. 1993;12:933–941
  18. Obermeier A, Bradshaw RA, Seedorf K, et al.  Neuronal differentiation signals are controlled by nerve growth factor receptor/trk binding sites for SHC and PLCγ. EMBO J. 1994;13:1585–1590
  19. Kahn CR. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes. 1994;43:1066–1084
  20. Murakami MS, Rosen OM. The role of insulin receptor autophosphorylation in signal transduction. J Biol Chem. 1991;266:22653–22660
  21. Hubbard SR, Wei L, Ellis L, et al.  Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature. 1994;372:746–754
  22. Sun XJ, Rothenberg P, Kahn CR, et al.  Structure of the insulin receptor substrate IRS1 defines a unique signal transduction protein. Nature. 1991;352:73–77
  23. Kovacina KS, Roth RA. Identification of SHC as a substrate of the insulin receptor kinase distinct from the GAP-associated 62 kDa tyrosine phosphoprotein. Biochem Biophys Res Commun. 1993;192:1303–1311
  24. Margolis R, Schell MJ, Taylor SI, et al.  Hepatocyte plasma membrane ecto-ATPase (ppl20/HA4) is a substrate for tyrosine kinase activity of the insulin receptor. Biochem Biophys Res Commun. 1990;166:562–566
  25. Sung CK, Sanchez-Margalet V, Goldfine ID. Role of p85 subunit of phosphatidylinositol-3-kinase as an adapter molecule linking the insulin receptor, p62, and GTPase-activating protein. J Biol Chem. 1994;269:12503–12507
  26. Lavan BE, Lienhard GE. The insulin-elicited 60-kDa phosphotyrosine protein in rat adipocytes is associated with phosphatidylinositol 3-kinase. J Biol Chem. 1993;268:5921–5928
  27. White M, Kahn CR. Mechanisms of insulin action. In:  Moller DE editors. Insulin Resistance. Chichester, UK: Wiley; 1993;p. 9–47
  28. Leevers S, Marshall CJ. MAP kinase regulation—The oncogene connection. Trends Cell Biol. 1992;2:283–286
  29. Ruderman JV. MAP kinase and the activation of quiescent cells. Curr Opin Cell Biol. 1993;5:207–213
  30. Egan SE, Giddings BW, Brooks MW, et al.  Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature. 1993;363:45–51
  31. Rozakis-Adcock M, Fernley R, Wade J, et al.  The SH2 and SH3 domains of mammalian Grb2 couple the EGF-R to the Ras activator mSos1. Nature. 1993;363:83–85
  32. Gale NW, Kaplan S, Lowenstein EJ, et al.  GRB2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature. 1993;363:88–92
  33. Li N, Batzer A, Daly R, et al.  Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to ras signalling. Nature. 1993;363:85–88
  34. Buday L, Downward J. Epidermal growth factor regulates p2lras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell. 1993;73:611–620
  35. Skolnik EY, Batzer A, Li N, et al.  The function of Grb2 in linking the insulin receptor to Ras signaling pathways. Science. 1993;260:1953–1955
  36. Skolnik EY, Lee CH, Batzer A, et al.  The domain containing protein Grb2 interacts with tyrosine-phosphorylated IRS1 and SHC: Implications for insulin control of ras signalling. EMBO J. 1993;12:1929–1936
  37. Simon MA, Dodson GS, Rubin GM. An SH3-SH2-SH3 protein is required for p2lRasl activation and binds to sevenless and Sos proteins in vitro. Cell. 1993;73:169–177
  38. Baltensperger K, Kozma LM, Cherniack AD, et al.  Binding of Ras activator son of sevenless to insulin receptor substrate 1 signaling complex. Science. 1993;260:1950–1952
  39. Bar-Sagi D. The Sos (SON of sevenless). Trends Endocrinol Metab. 1994;5:165–169
  40. Vojtek AB, Hollenberg SM, Cooper JA. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell. 1993;74:205–214
  41. Marshall CJ. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr Opin Gen Dev. 1994;4:82–89
  42. Schlessinger J. How receptor tyrosine kinases activate ras. Trends Biochem Sci. 1993;18:273–275
  43. Li W, Nishimura R, Kashishian A, et al.  A new function for a phosphotyrosine phosphatase: Linking Grb2-Sos to a receptor tyrosine kinase. Mol Cell Biol. 1994;14:509–517
  44. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature. 1988;334:661–665
  45. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 1992;58:607–614
  46. Rhee SG. Inositol phospholipids-specific phospholipase C: Interaction of the gamma isoform with tyrosine kinases. TIBS. 1991;16:297–301
  47. Sözeri O, Vollmer K, Liyanage M, et al.  Activation of the c-raf protein kinase by protein kinase C phosphorylation. Oncogene. 1992;7:2259–2262
  48. Kolch W, Heldecker G, Kochs G, et al.  Protein kinase C alpha activates raf-1 by direct phosphorylation. Nature. 1993;364:249–252
  49. Blenis J. Signal transduction via MAP kinases: Proceed at your own RSK. In: ed 2. Proc Natl Acad Sci USA. 90:1993;p. 5889–5892
  50. Lin T-A, Kong X, Haystead TAJ, et al.  PHAS-1 as a link between mitogen activated protein kinase and translation initiation. Science. 1994;266:653–656
  51. Chung J, Kuo CJ, Crabtree GR, et al.  Rapamycin-FKBP specifically blocks growth dependent activation of and signaling by the 70 kD S6 protein kinase. Cell. 1992;69:1227–1236
  52. Chung J, Grammer TC, Lemopn KP, et al.  PDGF- and insulin-dependent pp70S6K activation mediated by phosphatidylinositol-3-OH kinase. Nature. 1994;370:71–74
  53. Brown EJ, Albers MW, Bumshin T, et al.  A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature. 1994;369:756–758
  54. Cantley LC, Auger KR, Carpenter C, et al.  Oncogenes and signal transduction. Cell. 1991;64:281–302
  55. Rodriguez-Vaciana P, Warne PH, Dhand R, et al.  Phosphatidylinositol-3-OH kinase as a direct target of ras. Nature. 1994;370:527–532
  56. Dhand R, Hiles I, Panayotou G, et al.  The phosphatidylinositol-3 kinase is a dual specific enzyme: Autoregulation by an intrinsic serine kinase activity. EMBO J. 1994;13:522–533
  57. Lam K, Carpenter CL, Ruderman NB, et al.  The phosphatidylinositol 3 kinase serine kinase phosphorylates IRS1. In: Stimulation by insulin and inhibition by wortmannin. ed 2. J Biol Chem. 269:1994;p. 20648–20652
  58. Herman PK, Stack JH, Emr SD. A novel protein kinase homolog essential for protein sorting to the yeast lysosome-like vacuole. Cell. 1991;64:425–437
  59. Schu PV, Tagegawa K, Fry MJ, et al.  Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting. Science. 1993;260:88–91
  60. Okada T, Kawano T, Sakakibara T, et al.  Essential role of phosphatidylinositol 3 kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. J Biol Chem. 1994;269:3568–3573
  61. Chao MV. Neurotrophin receptors: A window into neuronal differentiation. Neuron. 1992;9:583–593
  62. Heldin C-H, Westermark B. Platelet-derived growth factor: Mechanism of action and possible in vivo function. Cell Regul. 1990;1:555–566
  63. Smits A, Hermansson M, Nistér M, et al.  Rat brain capillary endothelial cells express functional PDGF-B-type receptors. Growth Factors. 1989;2:1–8
  64. Smits A, Kato M, Westermark B, et al.  Functional PDGFβ receptors on rat neuronal cells suggest neurotrophic activity of PDGF. In: ed 2. Proc Natl Acad Sci USA. 88:1991;p. 8159–8163
  65. Wilks AF. Protein tyrosine kinase growth factor receptors and their ligands in development, differentiation, and cancer. Adv Cancer Res. 1993;60:43–73
  66. Seedorf K, Felder S, Millauer B, et al.  Analysis of platelet-derived growth factor receptor domain function using a novel chimeric receptor approach. J Biol Chem. 1991;266:12424–12431
  67. Lee J, Dull TJ, Lax I, et al.  HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor. EMBO J. 1989;8:167–173
  68. Riedel H, Dull TJ, Schlessinger J, et al.  Cytoplasmic domains determine signal specificity, cellular routing characteristics and influence ligand binding of epidermal growth factor and insulin receptors. EMBO J. 1989;8:2943–2954
  69. Chao MV. Growth factor signaling: Where is the specificity?. Cell. 1992;68:995–997
  70. Traverse S, Gomez N, Paterson H, et al.  Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. In: Comparison of the effects of nerve growth factor and epidermal growth factor. ed 2. Biochem J. 288:1992;p. 351–355
  71. Traverse S, Seedorf K, Paterson H, et al.  EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr Biol. 1994;8:694–701
  72. Cowley S, Paterson H, Kemp P, et al.  Activation of MAP kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH3T3 cells. Cell. 1994;77:841–852
  73. Mayer BJ, Baltimore D. Signaling through SH2 and SH3 domains. Trends Cell Biol. 1993;3:8–13
  74. Hug H, Sarre TF. Protein kinase C isoenzymes: Divergence in signal transduction. Biochem J. 1993;291:329–343
  75. Clemens MJ, Trayner I, Menaya J. The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation. J Cell Sci. 1992;103:881–887
  76. Lange-Carter CA, Pleiman CM, Gardner AM, et al.  A divergence in the MAP kinase regulatory network defined by MEK kinase and raf. Science. 1993;260:315–319
  77. Downward J, Waterfield MD, Parker PJ. Autophosphorylation and protein kinase C phosphorylation of the epidermal growth factor receptor. J Biol Chem. 1985;260:14538–14546
  78. Decker SJ. Phosphorylation of the erbB gene product from an avian erythroblastosis virus-transformed chicken fibroblast cell line. J Biol Chem. 1985;260:2003–2006
  79. Decker SJ, Ellis C, Pawson T, et al.  Effects of substitution of threonine 654 of the epidermal growth factor receptor on epidermal growth factor-mediated activation of phospholipase C. J Biol Chem. 1990;265:7009–7015
  80. Housley MD, Siddle K. Molecular basis of insulin receptor function. Br Med Bull. 1989;45:264–284
  81. Häring H, Kirsch D, Obermaier B, et al.  Tumor-promoting phorbol esters increase the Km of the ATP-binding site of the insulin-receptor-associated tyrosine kinase from rat adipocytes. Biochem J. 1986;234:59–66
  82. Obermaier B, Ermel B, Kirsch D, et al.  Catecholamines and tumor promoting phorbol ester inhibit insulin receptor kinase and induce insulin resistance in isolated human adipocytes. Diabetologia. 1987;30:93–98
  83. Considine RV, Caro JF. Protein kinase C: Mediator or inhibitor of insulin action?. J Cell Biochem. 1993;52:8–13
  84. Chin JE, Dickens M, Tavare JM, et al.  Overexpression of protein kinase C isoenzymes alpha, beta 1, gamma and epsilon in cells overexpressing the insulin receptor: Effects on receptor phosphorylation and signaling. J Biol Chem. 1993;268:6338–6347
  85. Pike LJ, Eakes AT. Epidermal growth factor stimulates the production of phosphatidylinositol monophosphate and the breakdown of polyphosphoinositides in A431 cells. J Biol Chem. 1987;262:1644–1651
  86. Hasegawa-Sasaki H, Lutz F, Sasaki T. Pathway of phospholipase C activation initiated with platelet-derived growth factor is different from that initiated with vasopressin and bombesin. J Biol Chem. 1988;263:12970–12976
  87. Chen WS, Lazar CS, Lund KA, et al.  Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation. Cell. 1989;59:33–43
  88. Rotin D, Margolis B, Mohammadi M, et al.  SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: Identification of tyr.992 as the high affinity binding site for SH2 domains of PLCγ. EMBO J. 1992;11:559–567
  89. Beguinot L, Werth D, Ito S, et al.  Functional studies on the EGF-receptor with an antibody that recognizes the intracellular portion of the receptor. J Biol Chem. 1986;261:1801–1807

PII: 0026-0495(95)90217-1

Metabolism - Clinical and Experimental
Volume 44 , Pages 24-32 , October 1995

Article Tools